Developer docs
API playgroundTry for free, no card

Search company profiles

Tidepool.org

Full company profile

uuid0008qne

Namestring
Tidepool.org
Legal namestring
Tidepool Project
Websiteurl
tidepool.org
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Tidepool Project, a 501(c)(3) nonprofit (EIN 46-2302287) headquartered at 555 Bryant St. #429, Palo Alto, CA, operates the Tidepool Data Platform, a hosted cloud-based system that ingests, normalizes, and visualizes diabetes device data from 50+ supported insulin pumps, continuous glucose monitors (CGMs), and blood glucose meters across manufacturers including Medtronic, Tandem, Omnipod, Dexcom, Abbott FreeStyle Libre, Roche Accu-Chek, LifeScan OneTouch, Senseonics Eversense, Companion Medical InPen, and Sequel. Client applications include Tidepool Web (browser), Tidepool Mobile, and the cross-platform Tidepool Uploader; the open-source codebase is published under github.com/tidepool-org. The company's flagship regulated product is Tidepool Loop, an FDA-cleared iOS automated insulin dosing (AID) application built on the #WeAreNotWaiting DIY community's original Loop app and commercially distributed under license by Sequel Med Tech as the twiist AID System Powered by Tidepool.

Tidepool serves three primary user groups: (1) people with diabetes (PwD), who create free personal accounts via app.tidepool.org and retain ownership of their data; (2) healthcare providers and clinics, who subscribe to Tidepool+ to access the Population Health Dashboard (TIDE Dashboard) with Clinic Sites, Tags, AGP-aligned statistics, and EHR PDF export; and (3) academic and clinical researchers, who access anonymized data through the Big Data Donation Project and collaborations such as the women's health initiative announced at ADA 2026 with ŌURA and the Milken Institute Women's Health Network. Layered programs include the Lighthouse Clinic Program, User Research Community, Period Project, and a Diabetes Care Management Program that reported a 1.59% HbA1c reduction and +13.4% Time in Range improvement over 24 weeks among uncontrolled type 2 diabetes patients in resource-limited settings.

The company's revenue model is hybrid and unusual for a software platform: as a 501(c)(3), it raises donations (public 'Donate' / 'Ways to Give' CTAs), generates subscription revenue from Tidepool+ Base and Workspace clinician/clinic plans (pricing undisclosed, gated by 'Clinician Sign Up'), and earns licensing royalties from OEM distribution of Tidepool Loop by Sequel Med Tech. The U.S.-only Terms of Use and explicit statement that 'Tidepool Apps are intended for use only in the United States' geographically scope both the regulatory posture and the addressable market, while ongoing 2025 releases (Tidepool Web 1.92.0/1.93.0 and Uploader 2.62.0-2.66.0) and a founder-CEO transition to Brandon Arbiter in October 2025 indicate an active product and governance cadence.

Short descriptiontext

Tidepool Project is a 501(c)(3) nonprofit operating the Tidepool Data Platform, a cloud-based system integrating data from 50+ diabetes devices for patients, clinicians, and researchers, including the FDA-cleared Tidepool Loop automated insulin delivery app.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPalo Alto, United States
HQ citystring
Palo Alto
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diabetes data platform, automated insulin delivery, continuous glucose monitoring, health data interoperability, diabetes population health
Industry2 codes
PRIMARYHLAHAHAF
Automated Insulin Delivery (AID) / Closed-Loop Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLACAFAG
Medical-Grade Device Connectivity & Device Management (MDM)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
Product category
Diabetes Data Management Software
GTM motion6 records

Each record includes

Type, Description, Source

Revenue model3 records
1Donations
TypeTransaction Fee
Description

Tidepool Project is a fully-qualified 501(c)(3) nonprofit (EIN 46-2302287). Public-facing "Donate" / "Ways to Give" CTAs and a Donations status component on status.tidepool.org indicate fundraising/donations as a primary revenue stream.

tidepool.org
2Tidepool+ clinician / clinic subscriptions
TypeSubscription Recurring
Description

Tidepool+ plans page (referenced as "Clinician Sign Up" under /providers/tidepoolplus/plans) offers Base and Workspaces tiers with patient limits (with some clinic accounts exempt from patient-limit enforcement), implying subscription-based clinic/workspace pricing.

tidepool.org
3OEM/licensing of Tidepool Loop
TypeLicensing Royalties
Description

Tidepool Loop is "commercially available as a licensed and third-party distributed product, most recently by Sequel Med Tech as twiist Loop", indicating licensing royalties from device partners.

tidepool.org
Marketing channels12 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
Pricing details2 tiers
1Personal / PwD User account — free self-serve sign-up via app.tidepool.org.
ModelFreemiumBilling cadencePay-as-you-go
Notes

Free for people with diabetes and their care team members. Pricing for individual personal accounts is not disclosed.

tidepool.org
2Tidepool+ for Healthcare Providers — Base / Workspace plans with patient limits (limits may be lifted for certain clinics such as those connected to Sequel twiist).
ModelSubscriptionBilling cadenceAnnual
Notes

Pricing for clinicians and clinic workspaces is not publicly disclosed. Access is gated through a "Clinician Sign Up" page.

tidepool.org
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 5 records shown
1Tidepool Loop
Description

FDA-cleared automated insulin delivery system built on the DIY diabetes community's original Loop app; commercially distributed by Sequel Med Tech as twiist Loop.

tidepool.org
+4 more records
Core offering1 text field

Tidepool operates a hosted cloud-based diabetes data platform that ingests, normalizes, and visualizes data from 50+ insulin pumps, continuous glucose monitors (CGMs), and blood glucose meters via a desktop Uploader, mobile app, and cloud-to-cloud integrations with Abbott, Dexcom, Sequel, and others. The platform serves both people with diabetes (free personal accounts with self-upload and care-team sharing) and healthcare providers (Tidepool+ subscription with Population Health / TIDE Dashboard analytics). Tidepool also develops Tidepool Loop, an FDA-cleared automated insulin dosing iOS app commercially distributed under license by Sequel Med Tech as twiist Loop.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 1.59% HbA1c reduction (24-week Diabetes Care Management Program in resource-limited settings, type 2 diabetes)
+2 more records
Product overview1 text field

Tidepool offers a unified, platform-based portfolio for diabetes data: the Tidepool Data Platform is the core hosted cloud platform that ingests device data; Tidepool Web, Tidepool Mobile, and the Tidepool Uploader are the client applications that feed and visualize that data; Tidepool Loop is Tidepool's FDA-cleared automated insulin delivery (AID) iOS app, commercially distributed by Sequel Med Tech as twiist Loop; Tidepool+ for Providers is the subscription tier for healthcare organizations; Tidepool for Telemedicine is the dedicated telemedicine workflow. Layered on top are research and clinical programs such as the Big Data Donation Project, Period Project, Lighthouse Clinic Program, and the Diabetes Care Management Program.

Product and service8 records
1Tidepool Data Platform
CategoryCore data platform
Description

Core hosted cloud platform that ingests, normalizes, and serves diabetes device data (insulin pumps, CGMs, blood glucose meters) from 50+ manufacturers via uploader, mobile app, and cloud-to-cloud integrations, exposing APIs and powering Tidepool Web, Mobile, and Uploader.

2Tidepool Web
CategoryWeb application
Description

Browser-based web application at app.tidepool.org for visualizing diabetes device data, including Daily View, Basics View, Trends View, BG Log View, AGP report, and TIDE / Population Health Dashboard with EHR PDF export, used by both personal users and clinicians.

3Tidepool Mobile
CategoryMobile application
Description

Mobile client used to upload diabetes device data from compatible devices (e.g., Dexcom G6 Mobile, Companion Medical InPen via Apple Health, Senseonics Eversense 365 CGM) and to view personal diabetes insights.

4Tidepool Uploader
CategoryDesktop application
Description

Cross-platform desktop application (Windows, macOS, Linux) that uploads data from connected diabetes devices (insulin pumps, CGMs, blood glucose meters) to a user's Tidepool account via USB or Bluetooth.

5Tidepool Loop
CategoryAutomated insulin delivery application
Description

FDA-cleared automated insulin delivery (AID) iOS app built on the foundation of the DIY Loop app, interoperating with compatible insulin pumps and CGMs, and commercially distributed by Sequel Med Tech as twiist Loop.

6Tidepool+ for Providers
CategoryClinic / provider subscription
Description

Subscription offering for healthcare providers and clinics that enables clinic-wide use of Tidepool Web, the Population Health / TIDE Dashboard, Clinic Sites/Tags, and connected devices workflows, with Base and Workspace tiers.

7Tidepool for Telemedicine
CategoryTelemedicine workflow
Description

Centralized workflow and resource hub for conducting successful telemedicine appointments between people with diabetes and their healthcare team using Tidepool-aggregated device data.

8Diabetes Care Management Program
CategoryCare management program
Description

24-week care management program delivered through Tidepool's platform for patients with uncontrolled type 2 diabetes in resource-limited healthcare settings, with documented HbA1c and Time in Range outcomes.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership25 partners
Strategic tierFlagship / CoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Sequel Med Tech commercially distributes Tidepool Loop under license as the twiist AID System Powered by Tidepool. The Tidepool Uploader and Tidepool Web are continuously updated to support twiist device data (bolus types, scheduled basal, button-initiated boluses, cassette changes, AGP/TIDE Dashboard). Patients connecting their My twiist Portal account to Tidepool are exempt from clinic patient-limit enforcement, indicating deep operational alignment.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partner on Tidepool's landmark women's health initiative announced at ADA 2026, aimed at building the largest opt-in anonymized dataset of biometric and diabetes device data for women across lifecycle stages.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborator on Tidepool's women's health initiative announced at ADA 2026 to address gaps in women's health research by aggregating biometric and diabetes device data for women.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner on a study demonstrating that personalized meal records and repeated meals with approximate carb-counting lead to better glycemic outcomes for automated insulin delivery (AID) users.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Research collaborator with Stanford University and Tidepool on personalized meal records and approximate carb-counting study for AID users, presented at ADA 2026.

6Abbott (FreeStyle Libre family)
Strategic tierCoreTypeTechnology or Integration
Description

Cloud-to-cloud integration of Abbott FreeStyle Libre (Libre 2, Libre 3, Libre 14-day, Libre Pro, Libre 3 Plus via Tandem, Libre Reader) with the Tidepool Data Platform. Listed as a Device Partner Cloud Connection on Tidepool Status.

tidepool.org
Strategic tierCoreTypeTechnology or Integration
Description

Cloud-to-cloud integration with Tidepool for Dexcom G6, G6 Mobile, and G7; Dexcom connection status tables featured in the TIDE Dashboard. Listed as a Device Partner Cloud Connection on Tidepool Status.

Strategic tierCoreTypeTechnology or Integration
Description

Integration support for uploading from Tandem t:slim X2 insulin pumps (Control-IQ), including Libre 3 Plus CGM data through Tandem. Tandem pump shutdown events are captured and displayed in Tidepool Web.

Strategic tierCoreTypeTechnology or Integration
Description

Uploader supports a broad range of legacy and current Medtronic insulin pumps with documented Dual/Square bolus display in Tidepool Web.

Strategic tierSupportingTypeTechnology or Integration
Description

Uploader supports Insulet Omnipod DASH data uploads, with explicit messaging that Omnipod 5 support is forthcoming.

Strategic tierSupportingTypeTechnology or Integration
Description

InPen smart insulin pen data is supported in Tidepool Mobile uploads via Apple Health.

Strategic tierSupportingTypeTechnology or Integration
Description

Senseonics Eversense 365 CGM data is uploaded into Tidepool via the Tidepool Mobile app.

Strategic tierSupportingTypeTechnology or Integration
Description

OneTouch Verio Flex, Verio Reflect, and Ultra Plus Flex blood glucose meters are supported via the Tidepool Uploader.

Strategic tierSupportingTypeTechnology or Integration
Description

Accu-Chek Guide, Guide Me, Aviva Connect, and Instant blood glucose meters are supported via the Tidepool Uploader.

Strategic tierSupportingTypeTechnology or Integration
Description

Contour Next, Contour Next One, Contour Next Link, Contour Next USB, Contour Next Gen, Contour Plus One, and Contour Plus Blue blood glucose meters are supported via the Tidepool Uploader.

16Arkray (GLUCOCARD Shine Connex, Shine Express, Shine XL)
Strategic tierSupportingTypeTechnology or Integration
Description

Arkray GLUCOCARD Shine family of blood glucose meters are supported via the Tidepool Uploader.

tidepool.org
Strategic tierSupportingTypeTechnology or Integration
Description

Trividia True Metrix blood glucose meters are supported via the Tidepool Uploader.

Strategic tierSupportingTypeTechnology or Integration
Description

ReliOn Platinum and Premier family blood glucose meters are supported via the Tidepool Uploader.

Strategic tierSupportingTypeTechnology or Integration
Description

CareSens N Premier, N Plus BT, and Pro blood glucose meters are supported via the Tidepool Uploader.

Strategic tierSupportingTypeTechnology or Integration
Description

Fora TN'G Voice Bluetooth Talking Blood Glucose Meter is supported via the Tidepool Uploader with improved Bluetooth upload experience.

Strategic tierSupportingTypeTechnology or Integration
Description

GlucoRx Nexus, Nexus Mini Ultra, Ultra Go, and HCT meters are supported via the Tidepool Uploader.

22Omnis Health (EmbraceTALK, EmbracePRO)
Strategic tierSupportingTypeTechnology or Integration
Description

Omnis EmbraceTALK and EmbracePRO blood glucose meters are supported via the Tidepool Uploader.

tidepool.org
Strategic tierSupportingTypeTechnology or Integration
Description

Keto Mojo meter support was added in Tidepool Uploader 2.66.0.

Strategic tierSupportingTypeTechnology or Integration
Description

Prodigy AutoCode blood glucose meter support added in Tidepool Uploader 2.65.0, with HI/LO reading upload bug fixed in 2.65.1.

25Brandon Arbiter (Co-founder, confirmed as CEO)
Strategic tierCoreTypeOthers
Description

Co-founder of Tidepool and type 1 diabetes patient, confirmed as CEO succeeding Howard Look on 2025-10-29; led Tidepool Loop and other development initiatives.

businesswire.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Glooko operates the Mobile Insulin Dosing System (MIDS) and a multi-device diabetes data aggregation platform that pulls data from most major pumps, CGMs, and BG meters into a single patient record for both patients and clinicians. It is the closest direct competitor to Tidepool's data platform, addressing the same interoperability pain point across both consumer and clinic workflows.

TypeDirect peer
Description

One Drop is a digital health platform combining a connected BG meter, CGM data integration, AI-driven predictions, and human coaching for diabetes and related cardiometabolic conditions. It directly overlaps with Tidepool's consumer app on CGM data visualization, insights, and care-team sharing for people with diabetes.

TypeBroad incumbent
Description

Dexcom is the leading CGM manufacturer and operates Dexcom Clarity, its own patient and clinician diabetes data visualization suite. While Tidepool integrates Dexcom G6/G7 via cloud-to-cloud, Clarity is a competing analytics destination, making Dexcom both a critical data partner and a broad incumbent competitor in the diabetes data layer.

TypeDirect peer
Description

mySugr is a patient-facing diabetes self-management app (now owned by Roche) that logs glucose, meals, insulin, and activity and connects to multiple BG meters and CGMs. It competes head-to-head with Tidepool's personal/PwD offering on accessibility and insights for people with diabetes, and through Roche's Accu-Chek installed base, shares the same multi-device interoperability narrative.

TypeBroad incumbent
Description

Abbott operates LibreView as the patient and clinician data platform for its FreeStyle Libre CGM family (Libre 2, 3, 14-day, Pro, 3 Plus via Tandem). LibreView competes with Tidepool Web for CGM data review while also being a key Tidepool data source, making Abbott a dual-role broad incumbent.

TypeBroad incumbent
Description

Tandem manufactures the t:slim X2 insulin pump with Control-IQ and runs t:connect as its patient/clinician data portal. Tandem pumps are a key Tidepool data source and t:connect competes with Tidepool+ for clinic workflows managing Tandem-heavy populations.

TypeBroad incumbent
Description

Sequel Med Tech is the licensed commercial distributor of Tidepool Loop as the twiist AID system, and is therefore both a flagship OEM partner and a competing pump+app offering in the AID market. Its commercial traction directly influences Tidepool Loop's user reach and licensing revenue.

TypeBroad incumbent
Description

Medtronic is the legacy insulin pump manufacturer (523, 530G, 630G, 640G, 670G, 723, 754) and operates CareLink as its proprietary patient and clinician data system. CareLink overlaps with Tidepool+ for clinicians managing Medtronic-heavy patient panels, even as Medtronic pump data feeds into Tidepool's multi-device view.

TypeEmerging player
Description

Diabeloop is a European medtech developing AI-driven automated insulin delivery algorithms (DBLG1, DBLG2, DBL-hu, DBL-T1) integrated with multiple pump and CGM partners. It is the most direct AID-algorithm peer to Tidepool Loop outside the US and competes for the same OEM-licensing model Tidepool is pursuing with Sequel.

TypeBroad incumbent
Description

Insulet manufactures the Omnipod patch pump family (DASH and the forthcoming Omnipod 5 AID) and provides its own companion app for bolus advice and pump data review. Insulet is both a Tidepool integration partner (DASH currently supported) and a broad incumbent with growing direct-to-consumer analytics that compete with Tidepool Web.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration54 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tidepool.org

Diabetes Data Management Softwaretidepool.org

Tidepool Project is a 501(c)(3) nonprofit operating the Tidepool Data Platform, a cloud-based system integrating data from 50+ diabetes devices for patients, clinicians, and researchers, including the FDA-cleared Tidepool Loop automated insulin delivery app.

What Tidepool.org does

Tidepool Project, a 501(c)(3) nonprofit (EIN 46-2302287) headquartered at 555 Bryant St. #429, Palo Alto, CA, operates the Tidepool Data Platform, a hosted cloud-based system that ingests, normalizes, and visualizes diabetes device data from 50+ supported insulin pumps, continuous glucose monitors (CGMs), and blood glucose meters across manufacturers including Medtronic, Tandem, Omnipod, Dexcom, Abbott FreeStyle Libre, Roche Accu-Chek, LifeScan OneTouch, Senseonics Eversense, Companion Medical InPen, and Sequel. Client applications include Tidepool Web (browser), Tidepool Mobile, and the cross-platform Tidepool Uploader; the open-source codebase is published under github.com/tidepool-org. The company's flagship regulated product is Tidepool Loop, an FDA-cleared iOS automated insulin dosing (AID) application built on the #WeAreNotWaiting DIY community's original Loop app and commercially distributed under license by Sequel Med Tech as the twiist AID System Powered by Tidepool.

Tidepool serves three primary user groups: (1) people with diabetes (PwD), who create free personal accounts via app.tidepool.org and retain ownership of their data; (2) healthcare providers and clinics, who subscribe to Tidepool+ to access the Population Health Dashboard (TIDE Dashboard) with Clinic Sites, Tags, AGP-aligned statistics, and EHR PDF export; and (3) academic and clinical researchers, who access anonymized data through the Big Data Donation Project and collaborations such as the women's health initiative announced at ADA 2026 with ŌURA and the Milken Institute Women's Health Network. Layered programs include the Lighthouse Clinic Program, User Research Community, Period Project, and a Diabetes Care Management Program that reported a 1.59% HbA1c reduction and +13.4% Time in Range improvement over 24 weeks among uncontrolled type 2 diabetes patients in resource-limited settings.

The company's revenue model is hybrid and unusual for a software platform: as a 501(c)(3), it raises donations (public 'Donate' / 'Ways to Give' CTAs), generates subscription revenue from Tidepool+ Base and Workspace clinician/clinic plans (pricing undisclosed, gated by 'Clinician Sign Up'), and earns licensing royalties from OEM distribution of Tidepool Loop by Sequel Med Tech. The U.S.-only Terms of Use and explicit statement that 'Tidepool Apps are intended for use only in the United States' geographically scope both the regulatory posture and the addressable market, while ongoing 2025 releases (Tidepool Web 1.92.0/1.93.0 and Uploader 2.62.0-2.66.0) and a founder-CEO transition to Brandon Arbiter in October 2025 indicate an active product and governance cadence.

Tidepool.org firmographics

Firmographics
Name
Tidepool.org
Legal name
Tidepool Project
Website
https://tidepool.org
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
51–100 employees
Short description
Tidepool Project is a 501(c)(3) nonprofit operating the Tidepool Data Platform, a cloud-based system integrating data from 50+ diabetes devices for patients, clinicians, and researchers, including the FDA-cleared Tidepool Loop automated insulin delivery app.
Ownership category
akta.pro rank

Tidepool.org industry classification

Industry
Product category
Diabetes Data Management Software
akta.pro industry
PRIMARYHLAHAHAF
Automated Insulin Delivery (AID) / Closed-Loop Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLACAFAG
Medical-Grade Device Connectivity & Device Management (MDM)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Diabetes data platform
  • Automated insulin delivery
  • Continuous glucose monitoring
  • Health data interoperability
  • Diabetes population health

Where Tidepool.org is headquartered

Location

Headquarters

HQ city
Palo Alto
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Tidepool.org business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Donations: Tidepool Project is a fully-qualified 501(c)(3) nonprofit (EIN 46-2302287). Public-facing "Donate" / "Ways to Give" CTAs and a Donations status component on status.tidepool.org indicate fundraising/donations as a primary revenue stream.
  2. Tidepool+ clinician / clinic subscriptions: Tidepool+ plans page (referenced as "Clinician Sign Up" under /providers/tidepoolplus/plans) offers Base and Workspaces tiers with patient limits (with some clinic accounts exempt from patient-limit enforcement), implying subscription-based clinic/workspace pricing.
  3. OEM/licensing of Tidepool Loop: Tidepool Loop is "commercially available as a licensed and third-party distributed product, most recently by Sequel Med Tech as twiist Loop", indicating licensing royalties from device partners.

Pricing tiers

ModelBillingPrice
FreemiumPay-as-you-goPersonal / PwD User account — free self-serve sign-up via app.tidepool.org.
SubscriptionAnnualTidepool+ for Healthcare Providers — Base / Workspace plans with patient limits (limits may be lifted for certain clinics such as those connected to Sequel twiist).

Go-to-market motion6 records

Distribution channels5 records

Marketing channels12 records

Tidepool.org product offering

Product offering

Core offering

Tidepool operates a hosted cloud-based diabetes data platform that ingests, normalizes, and visualizes data from 50+ insulin pumps, continuous glucose monitors (CGMs), and blood glucose meters via a desktop Uploader, mobile app, and cloud-to-cloud integrations with Abbott, Dexcom, Sequel, and others. The platform serves both people with diabetes (free personal accounts with self-upload and care-team sharing) and healthcare providers (Tidepool+ subscription with Population Health / TIDE Dashboard analytics). Tidepool also develops Tidepool Loop, an FDA-cleared automated insulin dosing iOS app commercially distributed under license by Sequel Med Tech as twiist Loop.

Product overview

Tidepool offers a unified, platform-based portfolio for diabetes data: the Tidepool Data Platform is the core hosted cloud platform that ingests device data; Tidepool Web, Tidepool Mobile, and the Tidepool Uploader are the client applications that feed and visualize that data; Tidepool Loop is Tidepool's FDA-cleared automated insulin delivery (AID) iOS app, commercially distributed by Sequel Med Tech as twiist Loop; Tidepool+ for Providers is the subscription tier for healthcare organizations; Tidepool for Telemedicine is the dedicated telemedicine workflow. Layered on top are research and clinical programs such as the Big Data Donation Project, Period Project, Lighthouse Clinic Program, and the Diabetes Care Management Program.

Differentiator

Problem solved

Functional benefit

Brands

  • Tidepool Loop: FDA-cleared automated insulin delivery system built on the DIY diabetes community's original Loop app; commercially distributed by Sequel Med Tech as twiist Loop.
  • Tidepool Data Platform
  • Tidepool Uploader
  • Tidepool Mobile
  • Tidepool+

Products and services

  • Tidepool Data Platform Core hosted cloud platform that ingests, normalizes, and serves diabetes device data (insulin pumps, CGMs, blood glucose meters) from 50+ manufacturers via uploader, mobile app, and cloud-to-cloud integrations, exposing APIs and powering Tidepool Web, Mobile, and Uploader.
  • Tidepool Web Browser-based web application at app.tidepool.org for visualizing diabetes device data, including Daily View, Basics View, Trends View, BG Log View, AGP report, and TIDE / Population Health Dashboard with EHR PDF export, used by both personal users and clinicians.
  • Tidepool Mobile Mobile client used to upload diabetes device data from compatible devices (e.g., Dexcom G6 Mobile, Companion Medical InPen via Apple Health, Senseonics Eversense 365 CGM) and to view personal diabetes insights.
  • Tidepool Uploader Cross-platform desktop application (Windows, macOS, Linux) that uploads data from connected diabetes devices (insulin pumps, CGMs, blood glucose meters) to a user's Tidepool account via USB or Bluetooth.
  • Tidepool Loop FDA-cleared automated insulin delivery (AID) iOS app built on the foundation of the DIY Loop app, interoperating with compatible insulin pumps and CGMs, and commercially distributed by Sequel Med Tech as twiist Loop.
  • Tidepool+ for Providers Subscription offering for healthcare providers and clinics that enables clinic-wide use of Tidepool Web, the Population Health / TIDE Dashboard, Clinic Sites/Tags, and connected devices workflows, with Base and Workspace tiers.
  • Tidepool for Telemedicine Centralized workflow and resource hub for conducting successful telemedicine appointments between people with diabetes and their healthcare team using Tidepool-aggregated device data.
  • Diabetes Care Management Program 24-week care management program delivered through Tidepool's platform for patients with uncontrolled type 2 diabetes in resource-limited healthcare settings, with documented HbA1c and Time in Range outcomes.

Quantifiable outcome

  • 1.59% HbA1c reduction (24-week Diabetes Care Management Program in resource-limited settings, type 2 diabetes)
  • +2 more outcomes

Companies that use Tidepool.org

Customer profile

Segments5 records

Ideal customer profiles3 records

Tidepool.org technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration54 records

AI capability4 records

Feature7 records

Tidepool.org partnerships and signals

Strategic signal

Partnerships

25 partnerships are on record, tiered flagship / core, core and supporting.

  • Sequel Med Tech (twiist AID System Powered by Tidepool)flagship / coreOEM/ Whitelabel/ Licensing PartnerSequel Med Tech commercially distributes Tidepool Loop under license as the twiist AID System Powered by Tidepool. The Tidepool Uploader and Tidepool Web are continuously updated to support twiist device data (bolus types, scheduled basal, button-initiated boluses, cassette changes, AGP/TIDE Dashboard). Patients connecting their My twiist Portal account to Tidepool are exempt from clinic patient-limit enforcement, indicating deep operational alignment.
  • ŌURAcoreStrategic or Co-development PartnerPartner on Tidepool's landmark women's health initiative announced at ADA 2026, aimed at building the largest opt-in anonymized dataset of biometric and diabetes device data for women across lifecycle stages.
  • Milken Institute Women's Health NetworkcoreStrategic or Co-development PartnerCollaborator on Tidepool's women's health initiative announced at ADA 2026 to address gaps in women's health research by aggregating biometric and diabetes device data for women.
  • Stanford UniversitycoreStrategic or Co-development PartnerAcademic research partner on a study demonstrating that personalized meal records and repeated meals with approximate carb-counting lead to better glycemic outcomes for automated insulin delivery (AID) users.
  • Replica HealthsupportingStrategic or Co-development PartnerResearch collaborator with Stanford University and Tidepool on personalized meal records and approximate carb-counting study for AID users, presented at ADA 2026.
  • Abbott (FreeStyle Libre family)coreTechnology or IntegrationCloud-to-cloud integration of Abbott FreeStyle Libre (Libre 2, Libre 3, Libre 14-day, Libre Pro, Libre 3 Plus via Tandem, Libre Reader) with the Tidepool Data Platform. Listed as a Device Partner Cloud Connection on Tidepool Status.
  • Dexcom (G6, G6 Mobile, G7)coreTechnology or IntegrationCloud-to-cloud integration with Tidepool for Dexcom G6, G6 Mobile, and G7; Dexcom connection status tables featured in the TIDE Dashboard. Listed as a Device Partner Cloud Connection on Tidepool Status.
  • Tandem Diabetes Care (t:slim X2)coreTechnology or IntegrationIntegration support for uploading from Tandem t:slim X2 insulin pumps (Control-IQ), including Libre 3 Plus CGM data through Tandem. Tandem pump shutdown events are captured and displayed in Tidepool Web.
  • Medtronic (523, 530G, 554, 630G, 640G, 670G, 723, 754)coreTechnology or IntegrationUploader supports a broad range of legacy and current Medtronic insulin pumps with documented Dual/Square bolus display in Tidepool Web.
  • Insulet (Omnipod DASH)supportingTechnology or IntegrationUploader supports Insulet Omnipod DASH data uploads, with explicit messaging that Omnipod 5 support is forthcoming.
  • Companion Medical (InPen)supportingTechnology or IntegrationInPen smart insulin pen data is supported in Tidepool Mobile uploads via Apple Health.
  • Senseonics (Ascensia) — Eversense 365 CGMsupportingTechnology or IntegrationSenseonics Eversense 365 CGM data is uploaded into Tidepool via the Tidepool Mobile app.
  • LifeScan (OneTouch Verio Flex, Verio Reflect, Ultra Plus Flex)supportingTechnology or IntegrationOneTouch Verio Flex, Verio Reflect, and Ultra Plus Flex blood glucose meters are supported via the Tidepool Uploader.
  • Roche (Accu-Chek Guide, Guide Me, Aviva Connect, Instant)supportingTechnology or IntegrationAccu-Chek Guide, Guide Me, Aviva Connect, and Instant blood glucose meters are supported via the Tidepool Uploader.
  • Ascensia (Bayer) — Contour Next familysupportingTechnology or IntegrationContour Next, Contour Next One, Contour Next Link, Contour Next USB, Contour Next Gen, Contour Plus One, and Contour Plus Blue blood glucose meters are supported via the Tidepool Uploader.
  • Arkray (GLUCOCARD Shine Connex, Shine Express, Shine XL)supportingTechnology or IntegrationArkray GLUCOCARD Shine family of blood glucose meters are supported via the Tidepool Uploader.
  • Trividia Health (True Metrix, True Metrix Pro, True Metrix Go)supportingTechnology or IntegrationTrividia True Metrix blood glucose meters are supported via the Tidepool Uploader.
  • ReliOn (Platinum, Premier Blu, Premier Classic, Premier Voice)supportingTechnology or IntegrationReliOn Platinum and Premier family blood glucose meters are supported via the Tidepool Uploader.
  • CareSens (N Premier, N Plus BT, Pro)supportingTechnology or IntegrationCareSens N Premier, N Plus BT, and Pro blood glucose meters are supported via the Tidepool Uploader.
  • ForaCare (TN'G Voice)supportingTechnology or IntegrationFora TN'G Voice Bluetooth Talking Blood Glucose Meter is supported via the Tidepool Uploader with improved Bluetooth upload experience.
  • GlucoRx (Nexus Mini Ultra and family)supportingTechnology or IntegrationGlucoRx Nexus, Nexus Mini Ultra, Ultra Go, and HCT meters are supported via the Tidepool Uploader.
  • Omnis Health (EmbraceTALK, EmbracePRO)supportingTechnology or IntegrationOmnis EmbraceTALK and EmbracePRO blood glucose meters are supported via the Tidepool Uploader.
  • Keto MojosupportingTechnology or IntegrationKeto Mojo meter support was added in Tidepool Uploader 2.66.0.
  • Prodigy (AutoCode)supportingTechnology or IntegrationProdigy AutoCode blood glucose meter support added in Tidepool Uploader 2.65.0, with HI/LO reading upload bug fixed in 2.65.1.
  • Brandon Arbiter (Co-founder, confirmed as CEO)coreOthersCo-founder of Tidepool and type 1 diabetes patient, confirmed as CEO succeeding Howard Look on 2025-10-29; led Tidepool Loop and other development initiatives.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Tidepool.org competitors and assessment

Company assessment

Direct peers

  • Glooko: Glooko operates the Mobile Insulin Dosing System (MIDS) and a multi-device diabetes data aggregation platform that pulls data from most major pumps, CGMs, and BG meters into a single patient record for both patients and clinicians. It is the closest direct competitor to Tidepool's data platform, addressing the same interoperability pain point across both consumer and clinic workflows.
  • One Drop: One Drop is a digital health platform combining a connected BG meter, CGM data integration, AI-driven predictions, and human coaching for diabetes and related cardiometabolic conditions. It directly overlaps with Tidepool's consumer app on CGM data visualization, insights, and care-team sharing for people with diabetes.
  • mySugr (Roche): mySugr is a patient-facing diabetes self-management app (now owned by Roche) that logs glucose, meals, insulin, and activity and connects to multiple BG meters and CGMs. It competes head-to-head with Tidepool's personal/PwD offering on accessibility and insights for people with diabetes, and through Roche's Accu-Chek installed base, shares the same multi-device interoperability narrative.

Broad incumbents

  • Dexcom (Dexcom Clarity): Dexcom is the leading CGM manufacturer and operates Dexcom Clarity, its own patient and clinician diabetes data visualization suite. While Tidepool integrates Dexcom G6/G7 via cloud-to-cloud, Clarity is a competing analytics destination, making Dexcom both a critical data partner and a broad incumbent competitor in the diabetes data layer.
  • Abbott Diabetes Care (FreeStyle Libre / LibreView): Abbott operates LibreView as the patient and clinician data platform for its FreeStyle Libre CGM family (Libre 2, 3, 14-day, Pro, 3 Plus via Tandem). LibreView competes with Tidepool Web for CGM data review while also being a key Tidepool data source, making Abbott a dual-role broad incumbent.
  • Tandem Diabetes Care (t:connect): Tandem manufactures the t:slim X2 insulin pump with Control-IQ and runs t:connect as its patient/clinician data portal. Tandem pumps are a key Tidepool data source and t:connect competes with Tidepool+ for clinic workflows managing Tandem-heavy populations.
  • Sequel Med Tech (twiist): Sequel Med Tech is the licensed commercial distributor of Tidepool Loop as the twiist AID system, and is therefore both a flagship OEM partner and a competing pump+app offering in the AID market. Its commercial traction directly influences Tidepool Loop's user reach and licensing revenue.
  • Medtronic Diabetes (CareLink): Medtronic is the legacy insulin pump manufacturer (523, 530G, 630G, 640G, 670G, 723, 754) and operates CareLink as its proprietary patient and clinician data system. CareLink overlaps with Tidepool+ for clinicians managing Medtronic-heavy patient panels, even as Medtronic pump data feeds into Tidepool's multi-device view.
  • Insulet (Omnipod): Insulet manufactures the Omnipod patch pump family (DASH and the forthcoming Omnipod 5 AID) and provides its own companion app for bolus advice and pump data review. Insulet is both a Tidepool integration partner (DASH currently supported) and a broad incumbent with growing direct-to-consumer analytics that compete with Tidepool Web.

Emerging players

  • Diabeloop: Diabeloop is a European medtech developing AI-driven automated insulin delivery algorithms (DBLG1, DBLG2, DBL-hu, DBL-T1) integrated with multiple pump and CGM partners. It is the most direct AID-algorithm peer to Tidepool Loop outside the US and competes for the same OEM-licensing model Tidepool is pursuing with Sequel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Tidepool.org social profiles

Digital presence

Tidepool.org compliance and trust

Trust signal

Compliance4 records

Tidepool.org financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tidepool.org leadership team

Management profile

Number of profiles

Profiles3 records

Tidepool.org funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tidepool.org M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tidepool.org

What does Tidepool.org do?

Tidepool operates a hosted cloud-based diabetes data platform that ingests, normalizes, and visualizes data from 50+ insulin pumps, continuous glucose monitors (CGMs), and blood glucose meters via a desktop Uploader, mobile app, and cloud-to-cloud integrations with Abbott, Dexcom, Sequel, and others. The platform serves both people with diabetes (free personal accounts with self-upload and care-team sharing) and healthcare providers (Tidepool+ subscription with Population Health / TIDE Dashboard analytics). Tidepool also develops Tidepool Loop, an FDA-cleared automated insulin dosing iOS app commercially distributed under license by Sequel Med Tech as twiist Loop.

Is Tidepool.org a public or private company?

Tidepool.org is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Tidepool.org founded?

Tidepool.org was founded in 2013. It employs 51 to 100 people.

Where is Tidepool.org based?

Tidepool.org is headquartered in Palo Alto, United States, in the North America region.

How does Tidepool.org make money?

Three revenue lines are on record. Donations are the primary driver. The others are tidepool+ clinician / clinic subscriptions and OEM/licensing of Tidepool Loop.

Who are Tidepool.org's main competitors?

Direct peers on record are Glooko, One Drop and mySugr (Roche). Broad incumbents are Dexcom (Dexcom Clarity), Abbott Diabetes Care (FreeStyle Libre / LibreView), Tandem Diabetes Care (t:connect), Sequel Med Tech (twiist), Medtronic Diabetes (CareLink) and Insulet (Omnipod). Diabeloop is listed as an emerging player.

Does Tidepool.org have an API?

Yes. Tidepool operates an API at api.tidepool.org (referenced as a component on the Tidepool Status page), used to power data exchange between the Tidepool Platform, Tidepool Web, Tidepool Mobile, Tidepool Uploader, and partner systems. Release notes reference additions of new API parameters (e.g., for Loop data filtering, smart data filtering when multiple CGMs are detected). The codebase is open source and available at github.com/tidepool-org. The API is partner-facing; Tidepool also provides hosted and source-code versions of its apps per its Terms of Use. Developer documentation is at developer.tidepool.org.

What industry is Tidepool.org in?

Tidepool.org's product category is Diabetes Data Management Software. Its primary akta.pro industry code is HLAHAHAF, Automated Insulin Delivery (AID) / Closed-Loop Systems, with a secondary code of HLACAFAG, Medical-Grade Device Connectivity & Device Management (MDM).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Tidepool Receives Breakthrough T1D Research Grant To Develop Automated Insulin Delivery Technology Without Meal AnnouncementsTidepool received a Breakthrough T1D research grant to develop an automated insulin delivery algorithm that adjusts dosing for meals without manual announcements. The grant will fund a clinical trial of the feature for Tidepool Loop, aiming to reduce daily management burdens. Results will inform a future FDA clearance submission.BioSpaceTidepool Showcases New Real-World Clinical Data and Landmark Women’s Health Initiative at ADA 2026Tidepool unveiled new clinical data and a women's health initiative at the ADA 2026 Scientific Sessions. A 24-week Diabetes Care Management Program in a resource-limited setting reduced HbA1c by 1.59% and increased Time in Range by 13.4%. The company also presented a collaborative study on meal logging and its impact on AID systems.Business Wire BlogTidepool Launches in Epic Showroom to Bring Diabetes Device Data into the Point of CareTidepool announced that Tidepool+ Direct Connect is now available in the Epic Showroom, built on SMART on FHIR to bring diabetes device data into Epic workflows. Clinicians can launch the app with a single click and review interactive data views without leaving Epic. The feature is part of Tidepool's ongoing work to improve diabetes data use during patient visits.TwiisttwiistTidepool has introduced the twiist Automated Insulin Delivery (AID) System, a new device for Type 1 diabetes management featuring personalized target ranges and post-meal carbohydrate adjustments. The system is powered by Tidepool Loop technology and offers control via iPhone, Apple Watch, or an on-pump button, with availability planned for select retail pharmacies.SequelmedtechSequel’s Automated Insulin Delivery: The Future of Diabetes Care is HereSequel Med Tech has introduced the twiist Automated Insulin Delivery system, an FDA-cleared device for people with type 1 diabetes that directly measures insulin volume and utilizes the Tidepool algorithm. The company is collaborating with DEKA Research & Development Corp., founded by inventor Dean Kamen, to advance this technology. Sequel aims to make the therapy more accessible through pharmacy channels.NatureThe adaptation of a single institution diabetes care platform into a nationally available turnkey solutionTidepool-TIDE is a turnkey, clinic-agnostic platform that adapts the TIDE diabetes care model for nationwide use. It reduces provider screen time and supports population-level CGM analysis, with partial randomization for evaluation. The platform is available as an upgrade for over 1,000 Tidepool clinics.Stock TitanSeamless Data: Tidepool and Abbott’s New Cloud-to-Cloud Integration PartnershipTidepool announced a cloud-to-cloud integration with Abbott to automatically stream FreeStyle Libre CGM data to its Tidepool+ platform. Clinics can initiate connections for Libre 1, 2, and 3 devices, merging data into Tidepool's Population Health Dashboard. The partnership aims to simplify data sharing and streamline diabetes care workflows.Business Wire BlogTidepool Will Integrate With Abbott’s FreeStyle Libre Portfolio for Seamless Cloud-to-Cloud DataTidepool announced a cloud-to-cloud data integration with Abbott's FreeStyle Libre CGM portfolio in the U.S., automatically streaming patient data to Tidepool+. Clinics can initiate connections with FreeStyle Libre 2 and 3 systems, merging data into Tidepool+'s Population Health Dashboard for clinician use.FrontlinemedtechCollaborate, Compete, or Coexist? Navigating the Landscape of Medical Device CompaniesThis article analyzes the strategic dynamics of collaboration, competition, and coexistence within the global medical device industry to drive innovation and patient care. It cites specific industry interactions, including partnerships between Medtronic and Tidepool, competitive rivalry in TAVR devices between Edwards Lifesciences and Medtronic, and regulatory frameworks like the EU MDR and US FDA Pre-Cert Program. The analysis highlights how these strategic choices impact market dynamics, intellectual property management, and healthcare outcomes.TmcnetTidepool Achieves SOC 2 Type II ComplianceTidepool announced SOC 2 Type II compliance with an unqualified opinion, audited by Prescient Assurance. The company, a diabetes management nonprofit, said the attestation validates its data platform's security and compliance. The audit confirms ongoing commitment to these standards.